What is IntelliProcessing?
IntelliProcessing is a technology provider specializing in ScreeningSource, a comprehensive platform designed to streamline drug testing, background checks, and case management for Third Party Administrators (TPAs), Clinics, Medical Review Officers (MROs), and other organizations. The platform offers robust compliance tools and revenue enhancement features, eliminating the need for clients to manage hardware or incur hidden costs. IntelliProcessing's commitment to user-friendly solutions is evident in its provision of free tools for random selection and DOT management, alongside seamless integration capabilities with diverse data sources. The company's focus is on empowering its clients with efficient operational tools.
How much funding has IntelliProcessing raised?
IntelliProcessing has raised a total of $19K across 1 funding round:
Debt
$19K
Debt (2021): $19K with participation from PPP
Key Investors in IntelliProcessing
PPP
Public-Private Partnership
What's next for IntelliProcessing?
With its Series A/B growth stage financing, IntelliProcessing is poised for significant expansion. The recent capital infusion is expected to fuel further development of its ScreeningSource platform, potentially broadening its market reach and enhancing its technological capabilities. Strategic investments will likely focus on optimizing compliance workflows and expanding integration partnerships, reinforcing IntelliProcessing's role as a key player in the background screening and compliance technology sector. The company's trajectory suggests a continued emphasis on providing scalable, cost-effective solutions to its target clientele.
See full IntelliProcessing company page
